CADASIL Argentine Registry (CADASILAR): Establishment of a Harmonized Multicenter Registry with Preliminary Clinical and Cognitive Insights from Latin America
Neuroepidemiology · 21.11.2026
DOI: 10.1159/ned/adwag028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroepidemiology, online erschienen am 21.11.2026. Verfasst von Carolina Agata Ardohain Cristalli und 19 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic small vessel disease. Despite extensive characterization in Europe and Asia, data from Latin America remain limited. This study aimed to describe the structure of the Argentine CADASIL registry (CADASILAR), a harmonized multicenter initiative, and to report preliminary findings from its cross-sectional cohort.
Methods
CADASILAR is an observational, referral-based, multicenter registry comprising two phases: a cross-sectional cohort (CADASILAR-C) and a planned three-year longitudinal follow-up (CADASILAR-Long). Here we report preliminary descriptive and bivariate analyses from CADASILAR-C. Definitive or possible CADASIL diagnoses were included based on genetic testing, skin biopsy, or clinical and neuroimaging criteria.
Results
A total of 109 patients were included in the CADASILAR-C cohort, 50.5% were female, and mean age at symptom onset was 42.4 ± 12 years. Ischemic stroke was the most frequent initial manifestation (28/109, 25.7%), followed by migraine with aura (19/109, 17.4%). History of cognitive decline was documented in 48.6% of patients (53/109). Among those with Mini-Mental State Examination data (49/109), 24.5% had scores indicative of cognitive impairment (10/49). An exploratory analysis among those with cognitive impairment showed a statistically significant difference in the frequency of hypertension (80.0% vs 33.3%, p=0.012), overweight (40.0% vs 10.3%, p=0.044), and obesity (40.0% vs 2.6%, p=0.004). On neuroimaging, periventricular and deep white matter hyperintensities, and temporal lobe lesions were the most frequent features observed. All genetic variants identified were cysteine-altering variants.
Conclusion
CADASILAR represents the first structured, multicenter effort to systematically characterize CADASIL in Latin America, providing a harmonized framework for the collection of clinical, cognitive, neuroimaging, and genetic data across centers. This approach aims to improve case identification, facilitate inter-cohort comparability, and support future longitudinal research in the region.
Zitieren
APA
Cristalli, C. A. A., Rosales, J., Alonso, J., Calandri, I., Gonzalez-Aquines, A., González, F., López, J. I., Morello-García, F., Selvaggi, V., Aguilar, M., Allegri, R., Chabriat, H., Chaves, H., Mezmezian, M. B., Muiño-Acuña, E., Lereis, V. P., Saks, D. G., Sevlever, G., Kauffman, M., & Cristalli, D. O. (2026). CADASIL Argentine Registry (CADASILAR): Establishment of a Harmonized Multicenter Registry with Preliminary Clinical and Cognitive Insights from Latin America. Neuroepidemiology. https://doi.org/10.1159/ned/adwag028
Vancouver
Cristalli CAA, Rosales J, Alonso J, Calandri I, Gonzalez-Aquines A, González F, et al. CADASIL Argentine Registry (CADASILAR): Establishment of a Harmonized Multicenter Registry with Preliminary Clinical and Cognitive Insights from Latin America. Neuroepidemiology. 2026. doi:10.1159/ned/adwag028
BibTeX
@article{Cristalli2026,
author = {Cristalli, Carolina Agata Ardohain and Rosales, Julieta and Alonso, Julián and Calandri, Ismael and Gonzalez-Aquines, Alejandro and González, Fabio and López, Juan Ignacio and Morello-García, Florentina and Selvaggi, Valentín and Aguilar, Martín and Allegri, Ricardo and Chabriat, Hugues and Chaves, Hernán and Mezmezian, Mónica Beatriz and Muiño-Acuña, Elena and Lereis, Virginia Pujol and Saks, Danit Gila and Sevlever, Gustavo and Kauffman, Marcelo and Cristalli, Diana Olga},
title = {CADASIL Argentine Registry (CADASILAR): Establishment of a Harmonized Multicenter Registry with Preliminary Clinical and Cognitive Insights from Latin America},
journal = {Neuroepidemiology},
year = {2026},
doi = {10.1159/ned/adwag028}
}
EUVIMED